| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CYRX | Option to purchase common stock | Options Exercise | $0 | -5K | -6.25% | $0.00 | 75K | Jul 1, 2021 | Common Stock | 5K | $3.07 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. |
| F2 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.01 to $62.935, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.04 to $63.19, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | 1/48 of the options vested on the 7th of each month for forty-eight months beginning on 8/19/2015. |